NCT01420822已完成不适用
Special Drug Use Investigation for ALLERMIST (Long Term)
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 500
- 主要终点
- The number of incidence of adverse events in Japanese subjects treated with ALLERMIST Nasal Spray for long-term use
研究概览
简要总结
This post-marketing surveillance study is to investigate possible problems or questions in safety and efficacy of ALLERMIST Nasal Spray for long-term use in Japanese subjects with allergic rhinitis under the conditions of actual practical use.
研究设计
- 研究类型
- Observational
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnosis of allergic rhinitis
- •Use ALLERMIST for the first time
- •Expected to use ALLERMIST for long-term (1 year).
排除标准
- •Subjects with infection which fluticasone is not effective
- •Subjects with deep mycosis
- •Subjects with hypersensitivity to fluticasone
研究组 & 干预措施
Subjects prescribed ALLERMIST
Subjects with allergic rhinitis prescribed ALLERMIST during study period
干预措施: Fluticasone (Drug)
结局指标
主要结局
The number of incidence of adverse events in Japanese subjects treated with ALLERMIST Nasal Spray for long-term use
时间窗: One year
Efficacy evaluation based on the subjective/objective symptom progresses in the period from the start of Allermist treatment to the end of the observation period
时间窗: One year
次要结局
未报告次要终点
研究者
相似试验
尚未招募
不适用
Post-marketing Surveillance Study for the Safety of Efluelda Tetra Pre-filled Syringe.ImmunizationInfluenza (Healthy Volunteers)NCT06694025Sanofi670
已完成
4 期
A Study to Evaluate the Safety and Efficacy of Lotemax Ophthalmic Suspension 0.5%Conjunctivitis, Seasonal AllergicConjunctivitis, Giant PapillaryInflammationNCT01437982Bausch & Lomb Incorporated140
已完成
不适用
Etanercept (Enbrel) Special Investigation (Regulatory Post Marketing Commitment Plan)ArthritisRheumatoidNCT01230177Pfizer3
已完成
不适用
Special Drug Use Investigation (Retrospective) for Arixtra® (Fondaparinux) Venous Thromboembolism Treatment (Over 100kg)AtaxiaNCT01428544GlaxoSmithKline5
已完成
不适用
Special Investigation For Long-Term Use Of Sildenafil (Regulatory Post Marketing Commitment Plan)Pulmonary HypertensionNCT00666198Pfizer's Upjohn has merged with Mylan to form Viatris Inc.3,337